Variable onset determinants and consequences of diabetes (db/db) obesity mutation expression: adrenergic promotion of utero-ovarian dysfunction.
Expression of the diabetes ( db/db) genotype mutation in female C57BL/KsJ mice induces a complex diabetes-obesity syndrome (DOS) responsible for reproductive tract involution promoted by hypercytolipidemia (HCL). Current studies define the complex and influences of the endometabolic variables that promote reproductive tract involution at the time of initial db/db mutation expression onset in female C57BL/KsJ mice. Littermate-paired, normal ( +/?) and db/db groups were isolated between 2 - 4 weeks of age and tissue samples analyzed for utero-ovarian alterations induced by the systemic, tissue, cellular and structural consequences of mutation expression. Significantly elevated body weights, blood glucose concentrations and serum insulin levels contrasted with atrophic utero-ovarian indices in db/db mutants compared to +/? groups. The onset of the db/db-expression promoted obesity and a mild hyperglycemic-hyperinsulinemic state. Initial db/db expression was characterized by significantly increased utero-ovarian insulin binding without variation in membrane insulin receptor concentrations. However, significant elevations in tissue glucose sequestration rates, norepinephrine (NE) concentrations and triacylglyceride lipase activity in db/db groups indicated that a complex of endometabolic counter-regulatory influences promoted the metabolic shunting of excess glucose and triglyceride moieties towards hypercytolipidemic storage. The resulting DOS-promoted accumulation of utero-ovarian cytolipidemic pools compromised reproductive tract cytoarchitecture in db/db mice. The results of these studies indicate that the inability of utero-ovarian tissue compartments to exhibit metabolic adaptation to the enhanced availability, transport and cellular imbibition of extracellular glucose-lipid pools promotes the initial cellular compromise recognized to induce reproductive failure in db/db mutants.
Garris
D R
DR
Division of Cell Biology and Biophysics, School of Biological Sciences, University of Missouri - Kansas City, Missouri 64110, USA. garrisd@umkc.edu
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D048909:Diabetes Complications / Q000097:blood / Q000235:genetics* / Q000503:physiopathology; D005260:Female; D006019:Glycolysis; D008049:Lipase / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D008954:Models, Biological; D009638:Norepinephrine / Q000378:metabolism; D009765:Obesity / Q000097:blood / Q000235:genetics / Q000503:physiopathology; D010053:Ovary / Q000503:physiopathology*; D011972:Receptor, Insulin / Q000378:metabolism; D014599:Uterus / Q000503:physiopathology*
D001786:Blood Glucose; D011972:Receptor, Insulin; D008049:Lipase; D009638:Norepinephrine